| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
XWEL sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 839.9K | - | - | |
| Dir | 265.2K | - | - | |
| Dir | 261.1K | - | - | |
| Dir | 240.7K | - | - | |
| Dir | 150.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2017 | Bernstein Bruce58 | Director | Buy | 6,500 | $1.14 | $7,395.00 | +1.6% | |
| Aug 14, 2017 | Bernstein Bruce58 | Director | Buy | 3,000 | $1.14 | $3,432.00 | +0.7% | |
| Aug 11, 2017 | Abbe Richard | Director | Buy | 8,047 | $1.16 | $9,357.86 | +3.0% | |
| May 23, 2017 | Perlman Andrew D | Chief Executive Officer | Buy | 30,686 | $1.78 | $54,730.85 | +10.1% | |
| May 22, 2017 | Heyer Andrew R67 | Director | Buy | 15,000 | $1.55 | $23,199.00 | New | |
| May 19, 2017 | Abbe Richard | Director | Buy | 39,670 | $1.54 | $61,139.40 | +17.4% | |
| May 18, 2017 | Bernstein Bruce58 | Director | Buy | 23,700 | $1.61 | $38,115.00 | +6.3% | |
| May 18, 2017 | Perlman Andrew D | Chief Executive Officer | Buy | 31,100 | $1.58 | $49,169.12 | +11.4% | |
| May 17, 2017 | Abbe Richard | Director | Buy | 15,500 | $1.54 | $23,823.50 | +7.3% | |
| Nov 15, 2016 | Bernstein Bruce58 | Director | Buy | 1,960 | $2.35 | $4,606.00 | +6.5% |